APT Medical Inc. (SHSE: 688617)
Health Care · Health Care Equipment & Supplies · CN
CN¥248.25
+5.17% today · -21.4% 1Y
APT Medical Inc. (SHSE: 688617) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $5.15B and employs 3,401 people.
Over the last twelve months the share price has lost 21.4%, trading between 176.28 and 337.20.
Tweenvest scores APT Medical Inc. across four factors: quality 81/100, value 68/100, growth 100/100, dividend 11/100. Its strongest factor is growth.
688617 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.15B
- Revenue (TTM)
- $426.40M
- P/E
- 37.58
- EPS
- 6.61
- Dividend yield
- 0.40%
- Beta (5Y)
- -0.32
- 52-week high
- CN¥337.20
- 52-week low
- CN¥176.28
- Avg volume (3M)
- —
- Shares outstanding
- 139.23M
- Employees
- 3,401
- Next earnings
- —
About APT Medical Inc.
APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
- ISIN
- CNE100004C45
- Founded
- 2002
- Listed since
- Jan 7, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MiniMed Group, Inc.NasdaqGS: MMED | $5.57B | $19.80 | +3.61% |
| Convatec Group PLCLSE: CTEC | $5.50B | £2.13 | -1.75% |
| Haemonetics CorporationNYSE: HAE | $5.44B | $119.47 | +17.46% |
| Teleflex IncorporatedNYSE: TFX | $5.26B | $124.19 | -0.23% |
| Merit Medical Systems, Inc.NasdaqGS: MMSI | $5.09B | $85.25 | +0.19% |
| Intco Medical Technology Co., Ltd.SZSE: 300677 | $4.51B | CN¥46.71 | -8.34% |
| Ansell LimitedASX: ANN | $4.35B | AU$45.10 | -0.88% |
| Integer Holdings CorporationNYSE: ITGR | $4.31B | $126.65 | +0.05% |
Figures last refreshed Oct 4, 2026.